AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Autoimmune Index report provides you with a perspective on the new commercial and clinical opportunities by assessing their clinical innovation aspect. Innoplexus’ AI based CTP engine was leveraged to predict the success probability of clinical assets.
Innoplexus’ CTP model forecasts the outcome of clinical studies and may serve as an early indicator for future stock movements.
Gene therapy promises to hold the cure to a number of diseases which, until now, have been considered incurable. By replacing a faulty gene in a patient’s DNA or repairing a defective gene by gene editing, gene therapy can provide a one-time treatment option for diseases such as genetic blindness, muscular dystrophy, blood cancer. Read our recent whitepaper: Advancements in gene therapy – usage of AAV vectors here.
Emergence of chimeric antigen receptor-t (CAR-T) cell therapies for cancer treatment